V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10007511 | 10005376 | 1.72 | 95.5 | null | 2018-12-01 | 2018-12-01 | BORTEZOMIB + THALIDOMIDE | 2 | N | 10558553 | BENDAMUSTINE + OBINUTUZUMAB |
| 10007512 | 10005376 | 1.58 | null | Palliative (P) | 2017-01-27 | 2018-02-20 | DA 3 + 10 | 2 | N | 10558553 | VEDEX |
| 10007513 | 10005377 | 1.75 | 86.199 | Disease modification (D) | 2019-06-21 | 2019-07-05 | Cisplatin + Pemetrexed | null | null | 10558747 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 10007514 | 10005378 | 1.71 | 65 | Disease modification (D) | 2015-08-15 | 2015-08-23 | Cyclophosphamide oral | 02 | N | 10558782 | IRINOTECAN |
| 10007515 | 10005378 | 1.74 | 94.7 | Palliative (P) | 2018-06-13 | 2018-07-11 | Sunitinib | N | N | 10558782 | VISMODEGIB |
| 10007516 | 10005380 | 1.57 | 89 | Palliative (P) | 2018-01-16 | 2018-01-16 | RUXOLITINIB | N | N | 10559205 | DOCETAXEL + TRASTUZUMAB |
| 10007517 | 10005381 | 1.77 | 88.15 | Palliative (P) | 2018-09-01 | 2018-09-28 | EOX | null | null | 10559404 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 10007518 | 10005381 | null | 54.6 | Palliative (P) | 2017-05-10 | 2017-06-07 | Vemurafenib | N | N | 10559404 | TOPOTECAN |
| 10007519 | 10005383 | 1.75 | 73 | Curative (C) | 2017-08-31 | 2017-09-03 | Cisplatin + Pemetrexed | N | N | 10559587 | METHOTREXATE INTRATHECAL |
| 10007520 | 10007676 | 1.85 | 77.3 | Curative (C) | 2017-12-21 | 2017-12-22 | CAPECITABINE + RT | 02 | N | 10559741 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10007521 | 10007676 | 1.66 | 51 | Palliative (P) | 2017-02-08 | 2017-02-09 | VEDex | N | N | 10559741 | CETUXIMAB |
| 10007522 | 10005386 | 1.71 | null | Palliative (P) | null | 2016-02-08 | Methotrexate intrathecal | 2 | N | 10559809 | CETUXIMAB + RT |
| 10007523 | 10005387 | 1.6 | null | Palliative (P) | 2017-02-24 | 2017-02-24 | Enzalutamide | N | null | 10560217 | IPILIMUMAB |
| 10007524 | 10005388 | 1.77 | 110 | Palliative (P) | 2017-09-26 | 2017-11-06 | EOX | 02 | N | 10560308 | CAPECITABINE + GEMCITABINE |
| 10007525 | 10005389 | 1.65 | 0 | null | 2015-03-22 | 2015-03-22 | Docetaxel + Trastuzumab (Maint) | 2 | N | 10560736 | MPV |
| 10007526 | 10005390 | null | 91.1 | null | 2019-02-26 | 2019-03-12 | Trifluridine + Tipiracil | 02 | N | 10561026 | FLUOROURACIL + RT |
| 10007527 | 10005392 | 1.63 | 49.7 | null | 2015-09-10 | 2015-10-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 1 | N | 10561219 | TRIPLE INTRATHECAL |
| 10007528 | 10005393 | null | 57.2 | Curative (C) | 2018-05-23 | 2018-05-23 | ECF | N | N | 10561995 | VEDEX |
| 10007529 | 10005393 | 1.81 | 0 | Palliative (P) | 2017-10-24 | 2017-10-24 | POMALIDOMIDE | 2 | N | 10561995 | CAV |
| 10007530 | 10005394 | 1.62 | 73 | Palliative (P) | 2018-07-14 | 2018-07-14 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 10562670 | IPILIMUMAB + NIVOLUMAB |
| 10007531 | 10005394 | 1.6 | 72.6 | Palliative (P) | 2017-09-30 | 2017-11-25 | CISPLATIN + VINORELBINE + RT | N | N | 10562670 | DABRAFENIB |
| 10007532 | 10005396 | 1.63 | null | Palliative (P) | 2018-08-07 | 2018-08-07 | AFATINIB | 02 | N | 10562814 | RITUXIMAB + VINBLASTINE |
| 10007533 | 10005401 | 1.61 | 69.5 | null | 2016-05-31 | 2016-08-07 | DA 3 + 10 | 02 | N | 10563102 | BORTEZOMIB |
| 10007534 | 10005402 | 1.6 | 79 | Palliative (P) | 2018-09-04 | 2018-09-10 | Melphalan IV High dose | N | N | 10563143 | CISPLATIN + VINORELBINE |
| 10007535 | 10005403 | 1.55 | 83.1 | Palliative (P) | 2016-06-27 | 2016-07-09 | Vinorelbine (oral) | N | N | 10563143 | CYCLOPHOSPHAMIDE |
| 10007536 | 10005405 | null | 78.5 | Curative (C) | 2015-12-25 | 2015-12-26 | Vinorelbine (oral) | 02 | N | 10563223 | DABRAFENIB + TRAMETINIB |
| 10007537 | 10005407 | 1.79 | 75 | Neo-adjuvant (N) | 2019-03-15 | 2019-03-21 | EOX | N | null | 10563459 | PAZOPANIB |
| 10007538 | 10007686 | null | null | Palliative (P) | 2014-01-05 | 2014-01-19 | Arsenic trioxide + Tretinoin | N | N | 10564423 | CETUXIMAB + RT |
| 10007539 | 10005410 | 1.8 | 95.7 | Palliative (P) | 2016-05-19 | 2016-06-04 | DHAP - R | N | N | 10564461 | ECARBOX |
| 10007540 | 10005410 | 1.64 | 87 | Curative (C) | null | 2019-08-14 | CISPLATIN + VINORELBINE | 2 | N | 10564461 | TEMOZOLOMIDE + RT |
| 10007541 | 10005412 | 0 | 67.35 | Curative (C) | 2020-01-16 | 2020-01-20 | CETUXIMAB | N | N | 10190683 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 10007542 | 10005412 | 1.75 | 78.4 | Curative (C) | 2015-01-16 | 2015-01-19 | GDP | 02 | N | 10190683 | ERLOTINIB |
| 10007543 | 10005412 | 1.7 | null | Neo-adjuvant (N) | 2017-10-22 | 2017-10-26 | Irinotecan 14day | N | N | 10190683 | LOMUSTINE + PROCARBAZINE |
| 10007544 | 10005414 | 1.59 | null | Curative (C) | 2018-11-10 | 2018-11-18 | AFATINIB | N | null | 10214598 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 10007545 | 10005414 | null | null | Palliative (P) | 2017-06-13 | 2017-07-05 | Vemurafenib | N | 0 | 10214598 | MELPHALAN |
| 10007546 | 10005414 | 1.5 | 53.1 | Palliative (P) | 2017-09-21 | 2017-10-19 | CISPLATIN + ETOPOSIDE | 2 | N | 10214598 | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB |
| 10007547 | 10005416 | 1.77 | 0 | Palliative (P) | 2014-11-21 | 2014-11-27 | Hydroxycarbamide | 1 | N | 10223520 | ECX |
| 10007548 | 10005420 | null | 112.8 | Palliative (P) | 2018-06-09 | 2018-06-25 | FEC 100 | 02 | N | 10226706 | RUXOLITINIB |
| 10007549 | 10005421 | 1.66 | 56.4 | Curative (C) | 2018-01-07 | 2018-01-16 | Mitomycin Intravesical | N | N | 10227056 | CRIZOTINIB |
| 10007550 | 10005422 | null | 55 | Palliative (P) | 2019-02-07 | 2019-02-09 | Hydroxycarbamide | 02 | N | 10228121 | LIPOSOMAL DOXORUBICIN |
| 10007551 | 10005422 | 1.62 | null | Palliative (P) | 2018-05-14 | 2018-05-17 | DA 3 + 10 | N | N | 10228121 | CHOP |
| 10007552 | 10005423 | 1.79 | 62.8 | Palliative (P) | 2017-10-29 | 2017-11-21 | CARFILZOMIB | N | null | 10234621 | LEAM |
| 10007553 | 10005423 | 1.67 | 100.3 | Palliative (P) | 2019-09-19 | 2019-09-19 | FLUOROURACIL + MITOMYCIN | N | N | 10234621 | CISPLATIN + VINORELBINE |
| 10007554 | 10005424 | null | 51.4 | Curative (C) | 2018-05-22 | 2018-05-23 | Bendamustine +/- Prednisolone | N | N | 10236230 | IRINOTECAN |
| 10007555 | 10005424 | 1.79 | 85 | Palliative (P) | 2018-10-27 | 2018-11-15 | LEAM | N | N | 10236230 | FEC |
| 10007556 | 10005425 | 1.6 | 85 | Palliative (P) | 2019-07-09 | 2019-07-24 | EOX | 02 | Y | 10237939 | CAPECITABINE + CISPLATIN |
| 10007557 | 10005426 | 1.87 | 75.8 | Curative (C) | 2017-12-21 | 2017-12-27 | Sorafenib | N | N | 10240541 | CAPECITABINE + CISPLATIN + RT |
| 10007558 | 10007695 | 1.75 | 104.7 | Disease modification (D) | 2017-09-25 | 2017-10-02 | Ibrutinib + Rituximab | N | N | 10240541 | NIVOLUMAB |
| 10007559 | 10005428 | 1.73 | 90 | Palliative (P) | 2017-05-22 | 2017-06-27 | Irinotecan | 2 | N | 10241713 | CAPECITABINE + IRINOTECAN |
| 10007560 | 10007696 | 1.69 | null | null | 2018-10-27 | 2019-01-26 | Pentostatin | N | N | 10242855 | ECF |